You have 9 free searches left this month | for more free features.

hepatitis B surface antigen

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Resolved Hepatitis B, CD20 Positive B-cell Lymphoma Trial (Entecavir)

Not yet recruiting
  • Resolved Hepatitis B
  • CD20 Positive B-cell Lymphoma
  • (no location specified)
Jul 10, 2022

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

Chronic Hepatitis B Trial in Melbourne (162, Placebo)

Recruiting
  • Chronic Hepatitis B
  • 162
  • Placebo
  • Melbourne, Australia
    Nucleus Network Pty Ltd
Jun 5, 2022

Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

Recruiting
  • Hepatitis B
  • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
Jan 12, 2023

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Australian Hepatitis and Risk Survey in Prisons

Recruiting
  • Hepatitis C
  • +2 more
  • Point-of-care hepatitis C antibody test
  • +5 more
  • Hume, Australian Capital Territory, Australia
  • +23 more
Apr 20, 2023

Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))

Withdrawn
  • Hepatitis B, Chronic
  • Entecavir (ETV)
  • +2 more
  • Kolding, Denmark
  • +29 more
Oct 27, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Cirrhosis, Liver, Vaccination Failure, HBV Trial (IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN)

Not yet recruiting
  • Cirrhosis, Liver
  • +3 more
  • IMIQUIMOD cream
  • HEPATITIS B SURFACE ANTIGEN
  • (no location specified)
Aug 27, 2021

Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)

Recruiting
  • Hepatitis B, Chronic
  • pegylated interferon-alfa
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Dec 20, 2021

Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

Completed
  • Chronic Hepatitis B
  • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
  • Amsterdam, Noord-Holland, Netherlands
    Academic Medical Center
Mar 25, 2021

Chronic Hepatitis b Trial in Taipei (Spirulina)

Completed
  • Chronic Hepatitis b
  • Spirulina
  • Taipei, Wenshan District, Taiwan
    Wanfang Hospital
Jan 20, 2021

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +12 more
Jan 17, 2023

Hepatitis B Trial in Hanoi (Sci-B-Vac-Lot B, Sci-B-Vac-Lot A, Engerix-B)

Completed
  • Hepatitis B
  • Sci-B-Vac-Lot B
  • +2 more
  • Hanoi, Vietnam
    National Institute of Hygiene and Epidemiology (NIHE)
Jul 18, 2022

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Chronic Hepatitis B Trial in Beijing (TCR-T)

    Active, not recruiting
    • Chronic Hepatitis B
    • TCR-T
    • Beijing, China
      The Fifth Medical Center of PLA General Hospital
    Jun 13, 2023

    Chronic Hepatitis B Trial in Hong Kong (Treatment cessation)

    Completed
    • Chronic Hepatitis B
    • Treatment cessation
    • Hong Kong, Hong Kong
      Department of Medicine, The University of Hong Kong, Queen Mary
    Feb 6, 2020

    Chronic Hepatitis B Trial (Imdusiran (AB-729))

    Not yet recruiting
    • Chronic Hepatitis B
    • Imdusiran (AB-729)
    • (no location specified)
    Nov 30, 2023

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

    Recruiting
    • Hepatitis B, Chronic
    • Vancouver, British Columbia, Canada
    • +31 more
    Jan 17, 2023

    Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

    Recruiting
    • AIDS
    • Hepatitis B
    • Peginterferon alfa-2b Injection
    • Guangzhou, Guangdong, China
      Guangzhou Eighth People's Hospital, Guangzhou Medical University
    Aug 10, 2023

    Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

    Not yet recruiting
    • Chronic Hepatitis B
    • HRS9950 tablets
    • HRS9950 placebo tablets
    • (no location specified)
    Jun 7, 2023

    Hepatitis C, Chronic Trial (HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests, DAAs)

    Completed
    • Hepatitis C, Chronic
    • HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests
    • DAAs
    • (no location specified)
    Nov 22, 2019

    Hepatitis B Vaccination Trial in Baltimore (Subcutaneous fat injection of Recombivax-HB, Intramuscular injection of

    Completed
    • Hepatitis B Vaccination
    • Subcutaneous fat injection of Recombivax-HB
    • Intramuscular injection of Recombivax-HB
    • Baltimore, Maryland
      University of Maryland, Baltimore, Center for Vaccine Developmen
    Nov 12, 2019

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

    Terminated
    • Hepatitis B, Chronic
    • Hillsborough, New Jersey
    • +11 more
    Dec 28, 2022

    Chronic Hepatitis B Virus Trial in San Francisco (Stop NA therapy)

    Active, not recruiting
    • Chronic Hepatitis B Virus
    • Stop NA therapy
    • San Francisco, California
    • +1 more
    Mar 29, 2021